terazosin hydrochloride

Generic: terazosin hydrochloride

Labeler: preferred pharmaceuticals, inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin hydrochloride
Generic Name terazosin hydrochloride
Labeler preferred pharmaceuticals, inc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 1 mg/1

Manufacturer
Preferred Pharmaceuticals, Inc

Identifiers & Regulatory

Product NDC 68788-9817
Product ID 68788-9817_1aad6bb0-ce5d-45bb-afe1-4b37e22cb761
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2026-12-31
Marketing Start 2012-04-05

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687889817
Hyphenated Format 68788-9817

Supplemental Identifiers

RxCUI
313215 313217 313219
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin hydrochloride (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (68788-9817-1)
  • 30 CAPSULE in 1 BOTTLE (68788-9817-3)
  • 60 CAPSULE in 1 BOTTLE (68788-9817-6)
  • 90 CAPSULE in 1 BOTTLE (68788-9817-9)
source: ndc

Packages (4)

68788-9817-1 100 CAPSULE in 1 BOTTLE (68788-9817-1) 68788-9817-3 30 CAPSULE in 1 BOTTLE (68788-9817-3) 68788-9817-6 60 CAPSULE in 1 BOTTLE (68788-9817-6) 68788-9817-9 90 CAPSULE in 1 BOTTLE (68788-9817-9)

Ingredients (1)

terazosin hydrochloride (1 mg/1)

Linked Drug Pages (1)

Terazosin hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1aad6bb0-ce5d-45bb-afe1-4b37e22cb761", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313215", "313217", "313219"], "spl_set_id": ["9d8fd052-b478-447e-a884-74fcd21275bb"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68788-9817-1)", "package_ndc": "68788-9817-1", "marketing_start_date": "20120405"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68788-9817-3)", "package_ndc": "68788-9817-3", "marketing_start_date": "20120405"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (68788-9817-6)", "package_ndc": "68788-9817-6", "marketing_start_date": "20120405"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (68788-9817-9)", "package_ndc": "68788-9817-9", "marketing_start_date": "20120405"}], "brand_name": "Terazosin hydrochloride", "product_id": "68788-9817_1aad6bb0-ce5d-45bb-afe1-4b37e22cb761", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "68788-9817", "generic_name": "Terazosin hydrochloride", "labeler_name": "Preferred Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin hydrochloride", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "1 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20120405", "listing_expiration_date": "20261231"}